Last reviewed · How we verify
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.
Details
| Lead sponsor | Baker Heart and Diabetes Institute |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 820 |
| Start date | Thu Nov 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Dec 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Heart Failure
Interventions
- Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)
- Usual care
Countries
Australia